1. The Development of Virus-Resistant Alfalfa, Medicago sativa L
- Author
-
Loesch-Fries Ls, Jarvis-Eagan N, Nelson Se, Merlo Dj, Rashka Ke, Halk El, Krahn Kj, Hill Kk, Liao Lw, and Mathewson Rs
- Subjects
animal structures ,viruses ,Transgene ,Kanamycin Resistance ,Biomedical Engineering ,Enzyme-Linked Immunosorbent Assay ,Bioengineering ,Applied Microbiology and Biotechnology ,Virus ,Microbiology ,Capsid ,Mosaic Viruses ,Botany ,Cultivar ,Gene ,Plant Diseases ,Mosaic virus ,biology ,Inoculation ,fungi ,food and beverages ,Protoplast ,biology.organism_classification ,Alfalfa mosaic virus ,DNA, Viral ,embryonic structures ,Molecular Medicine ,Electrophoresis, Polyacrylamide Gel ,Medicago sativa ,Biotechnology - Abstract
We have generated more than 100 transgenic alfalfa plants, via Agrobacterium-mediated gene transfer, from genotypes selected from five alfalfa cultivars. These plants express the genes for kanamycin resistance and for the coat protein of alfalfa mosaic virus (AMV). The strongest expressers accumulated nearly 500 ng coat protein per mg soluble leaf protein. AMV inoculation of protoplasts from these strong expressers indicated that they were resistant to infection by AMV, while protoplasts from plants containing about a hundred-fold less coat protein and from control untransformed plants were not. Transgenic alfalfa plants containing large amounts of coat protein were, likewise, resistant to AMV. These plants did not develop systemic infections following inoculation with up to 50 micrograms/ml AMV, while inoculated control plants developed systemic infections following inoculation with as little as 10 micrograms/ml AMV. These results demonstrate that expression of the AMV coat protein gene confers resistance to AMV infection in transgenic alfalfa plants.
- Published
- 1991
- Full Text
- View/download PDF